This Sources Sought opportunity from Department Of Defense was posted on April 8, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Inhaled Nitric Oxide

Closed

W81K00-26-Q-A126Federal

Submission Closed04/15/2026, 02:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

DIBBS

TEST KIT, CHLAMYDIA TRA

Solicitation # SPE2DS-26-T-423P

Solicitation SPE2DS-26-T-423P, issued by the DLA Troop Support Medical Supply Chain, is a request for quotes for one test kit for the detection of Chlamydia trachomatis, identified by NSN 6550-01-725-3600. The kit is designed for in vitro diagnostic use to perform qualitative direct immunofluorescence tests on human urogenital and ophthalmic specimens, as well as for confirming Chlamydia in cell culture. Each kit must provide materials for 50 tests and include two positive control slides, mounting fluid, Chlamydia test reagent, and instructions for use. The required delivery date is September 14, 2026, with the place of performance and delivery located in San Antonio, Texas. The procurement falls under NAICS code 325413 and is subject to destination inspection and acceptance. Packaging must adhere to commercial standards, MIL-STD-2073-1E, and RP001, while marking must comply with Medical Marking Standard No. 1. The contract incorporates various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and the Hazard Communication Standard for hazardous materials. Payment and invoicing are to be processed electronically through the Wide Area WorkFlow system. Quotes must be submitted via the DIBBS portal by September 16, 2026, and the award may be processed through an automated system, with a price evaluation preference applied to HUBZone concerns.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-421Y

Solicitation SPE2DS-26-T-421Y is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. The kits, identified by NSN 6550-01-716-1573, must be delivered to the USNS John L. Canley T-ESB-6 in San Diego, California. Each case contains 12 kits with two tests per kit. The items are subject to a non-extendable shelf life of 12 months, and no more than one month may have elapsed from the date of manufacture to the date of delivery to the government. The contractor must adhere to strict storage and marking requirements, maintaining the kits between 2-30 degrees Celsius and labeling all materials according to Medical Marking Standard No. 1. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers in accordance with RP001 DLA Packaging Requirements. All labels must include the contract or lot number and the date of manufacture and expiration. Quotes must be submitted via the DIBBS system by September 16, 2026, and the award will be automated. Payment and receiving reports are to be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Blood Bank Reagents and Consumables Supply

POSTED

DEADLINE

Urine Drug Screening and Confirmation Laboratory Services

Residential Reentry - Co

POSTED

DEADLINE

Intent to Sole Source- Automated Blood Bank Instrumentation

Solicitation # PZIBABPA

The Air Force Life Cycle Management Center intends to award a sole-source, firm-fixed-price Blanket Purchase Agreement to QuidelOrtho Sales Company, LLC. This contract provides automated blood bank instrumentation, reagents, consumables, and associated support for the 88th Medical Group Laboratory Flight at Wright-Patterson Air Force Base. The requirement specifies a fully automated, continuous-access system that integrates with laboratory information systems, including MHS Genesis, to ensure uninterrupted blood bank operations. The decision to sole source follows extensive market research and a Sources Sought notice, which determined that QuidelOrtho is the only available source capable of meeting the minimum technical requirements. These requirements include specific methodology, FDA-approved reagent kits, and a single-platform solution for blood bank testing. The procurement falls under NAICS code 325413. Interested parties wishing to challenge the sole-source intent must submit a detailed capability statement to the designated points of contact by September 22, 2026.

POSTED

DEADLINE

Supplier of I-STAT PT Plus Control Reagent Level 2

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-26-T-415T

This contract is for the procurement of one box of PT Plus Control Reagent Level 2, used for coagulation testing with the i-STAT PT Plus cartridge on the i-STAT 1 Government Field Kit analyzer. The item is issued in boxes containing ten 1.0ml units and is identified by NSN 6550-01-725-6872. Delivery is required within 20 days after the order is placed. The reagent has a non-extendable shelf life of 12 months, and no more than one month may elapse between the date of manufacture and delivery to the government. Storage requires refrigeration between 2 to 8 degrees Celsius, and the product must not be frozen. All supplies must adhere to DLA packaging and medical marking standards, including specific labeling for manufacture and expiration dates, contract numbers, and lot numbers.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-26-T-415M

This contract is for the procurement of one box of i-STAT PT Plus Control Reagent Level 1, used for coagulation testing on the i-STAT 1 Government Field Kit blood gas analyzer. Each box contains ten 1.0 ml units. The item is subject to a non-extendable shelf life of 12 months, with a requirement that no more than one month passes between the date of manufacture and the date of delivery to the government. Proper refrigeration is required for storage between 2 to 8 degrees Celsius. The supplier must adhere to DLA packaging and medical marking standards, ensuring each unit is sealed and protected in commercial shipping containers. All labels must clearly state the contract number, lot number, and dates of manufacture and expiration. Delivery is required within 20 days after the order is placed. Bidders are required to specify the source and part number being supplied.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DS-26-T-409W

This contract is for the procurement of one benzene chip designed for use with a CMS analyzer. The chip features ten measurement capillaries filled with a substance-specific reagent system, providing a measuring range of 0.5 to 10.0 ppm and a total capacity of ten tests. The item is identified by NSN 6550-01-530-9389 and must be delivered within 20 days after the order is placed. The product is subject to a non-extendable shelf life of 24 months, with a requirement that no more than three months elapse between the date of manufacture and the date of delivery to the government. Packaging must meet commercial standards and be secured in sealed unit containers to prevent damage. All labeling and marking must comply with Medical Marking Standard No. 1, including the date of manufacture, expiration or retest date, and the contract or lot number.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, BACTERIA DETE

Solicitation # SPE2DS-26-T-410L

This solicitation, issued by the Department of Defense Medical Supply Chain, is for the procurement of four packages of Pathogel bacteria determination test kits under solicitation number SPE2DS-26-T-410L. These single-use, self-contained kits utilize a selective medium and special gelling agent to detect coliform, E. coli, and hydrogen sulfide producing enterobacteriaceae, such as Salmonella and Citrobacter, in food, beverages, and water. The kits provide results within 28 hours and are capable of detecting 1CFU per 100ml in water and 1CFU per 3ml in juice. Each package contains 25 units. The contract specifies a non-extendable shelf life of six months, requiring that no more than one month has elapsed from the date of manufacture to the date of delivery. Items must be stored and shipped between 15 and 25 degrees Celsius and must adhere to Medical Marking Standard No. 1 and DLA packaging requirements. Delivery is required within 20 days after receipt of the order for the place of performance at Fort Riley. Bidders are required to specify the source and part number being supplied for NSN 6550-01-723-3649.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Cepheid Reagents and Consumables BPA

Solicitation # 246-26-Q0040

The Indian Health Service Lawton Service Unit is establishing a Blanket Purchase Agreement for molecular diagnostic reagent test kits, cartridges, and consumables specifically for the Cepheid GeneXpert Analyzer. This combined solicitation, identified as 246-26-Q0040, is set aside for Indian Small Business Economic Enterprises under NAICS code 325413. The contract is structured as an IDIQ agreement consisting of a base year and four option years, with performance taking place in Lawton, Oklahoma. The scope of work includes the provision of reagent items based on estimated annual volumes and requires strict adherence to FDA regulations and CLIA 88 standards. Eligible offerors must provide self-certification of their status as an Indian Economic Enterprise via the Buy Indian Act representation form. The response deadline for this requirement is September 14, 2026, with the primary point of contact being Audrey Yackeyonny.

Indian Health Service

POSTED

DEADLINE

First To Know® Syphilis Rapid Test Kit Supply

PROC OA DIVISION OF PURCHASING PROCUREMENTS

POSTED

4 days ago

DEADLINE

in 6 days

General Info

Agency

Department Of Defense → W40M MRC0 WestView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

DWG, TX, 78234, USA

Set-Aside

NONE

Documents

(1)

Salient Characteristics for Inhaled Nitric Oxide Therapy System

PDF•specifications

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedApr 8

Sources Sought

Response DeadlineApr 15

Deadline has passed

Submission Closed

04/15/2026, 02:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → W40M MRC0 West

Contacts2 people available

OfficeJBSA FT SAM HOUSTON, TX, 78234-4504, USA

Organization / Agency

Department Of Defense → W40M MRC0 West

View Agency Profile

Office AddressJBSA FT SAM HOUSTON, TX, 78234-4504, USA

Contacts

Jaclyn Evans

contact@example.gov

James M Davis

contact@example.gov

Full Description

The purpose of this sources sought notice is to conduct market research to determine if responsible sources exist by determining if this effort can be successfully competed and/or set-aside for Small Businesses. The proposed North American Industry Classification System (NAICS) Code is 325413 – In-Vitro Diagnostics Substance Manufacturing which has a size standard of 1,250 employees. The Government will use this information to determine the best acquisition strategy for this procurement. The Government is interested in all large and small businesses to include 8(a), Service-Disabled Veteran-Owned, HubZone, and Women-Owned small business concerns.

The Medical Readiness Contracting Office-West (MRCO-W), JBSA, Fort Sam Houston, Texas, is seeking potential sources to establish an Inhaled Nitric Oxide Gas contract in support of the Respiratory Department at Brooke Army Medical Center (BAMC), JBSA – Fort Sam Houston, Texas.

This requirement is for the purchase of inhaled Nitric Oxide (iNO) to be used in various clinics within Brooke Army Medical Center (BAMC) to improve oxygenation for patients undergoing various procedures. The Inhaled Nitric Oxide must adhere to the entirety of the list of salient characteristics outlined in Attachment (1). Period of Performance: One (1) base year (01 JAN 2027 – 31 DEC 2027) plus four (4) option years (01 JAN 2028 - 31 DEC 2032).

This is not a solicitation. This information is for planning purposes only and is not to be construed as a commitment by the Government, implied or otherwise, to issue a solicitation or award a contract. Contractors responding to this sources sought notice are advised their response does not ensure participation in future solicitations or contract awards. The Government will not reimburse any company or individual for any expense associated with preparation or participation in this research. Interested parties should e-mail responses to jaclyn.v.evans.civ@health.mil.